Advertisements


We are Sorry, This Page doesn't Exist


Sarepta Therapeutics News: SRPT Stock Skyrockets 36% on FDA Approval of Muscular Dystrophy Drug

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Sarepta Therapeutics (SRPT) has good news for SRPT stock investors concerning its tr.....»»

Category: topSource: investorplaceDec 15th, 2019

Sarepta stock surges more than 20% as FDA finally OKs muscular dystrophy drug

Sarepta Therapeutics Inc. shares surged in the extended session Thursday after the genetic medicine company said the Food and Drug Admin.....»»

Category: topSource: marketwatchDec 12th, 2019

First Week of May 2020 Options Trading For Sarepta Therapeutics (SRPT)

Stock Options Channel.....»»

Category: topSource: redinewsSep 24th, 2019

June 15th Options Now Available For Sarepta Therapeutics (SRPT)

Stock Options Channel.....»»

Category: topSource: redinewsApr 14th, 2018

November 2nd Options Now Available For Sarepta Therapeutics (SRPT)

Stock Options Channel.....»»

Category: topSource: redinewsSep 13th, 2018

Is Sarepta Therapeutics Inc (SRPT) A Good Stock To Buy?

Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dolla.....»»

Category: topSource: insidermonkeyDec 8th, 2018

April 18th Options Now Available For Sarepta Therapeutics (SRPT)

Stock Options Channel.....»»

Category: topSource: redinewsJan 14th, 2019

June 21st Options Now Available For Sarepta Therapeutics (SRPT)

Stock Options Channel.....»»

Category: topSource: redinewsFeb 1st, 2019

Asia and Europe Markets Advance; Crude Oil Back Near $80 - Global Markets Today While US Slept

On Friday, U.S. stock markets surged as a softer jobs report reinforced the argument for Fed rate cuts. The Nasdaq led with Apple's buyback news. read more.....»»

Category: blogSource: benzingaMay 6th, 2024

Sarepta"s stock is up 11% on positive data from clinical trial for Duchenne treatment

Shares of Sarepta Therapeutics Inc. gained 11.3% in trading on Tuesday after the co.....»»

Category: topSource: marketwatchMay 18th, 2021

Why F-star Therapeutics" Stock Is Trading Lower Today

F-star Therapeutics (NASDAQ:FSTX) shares are trading lower after the company priced its 9.29 million shares common stock offering at $7 per share. read more.....»»

Category: blogSource: benzingaMay 7th, 2021

Why Athenex"s Stock Is Trading Higher Today

Athenex's (NASDAQ:ATNX) shares are trading higher after the company announced it acquired Kuur Therapeutics. read more.....»»

Category: blogSource: benzingaMay 5th, 2021

Why Sorrento Therapeutics" Stock Is Trading Higher Today

Sorrento Therapeutics (NASDAQ: SRNE) shares are trading higher after the company received FDA clearance to proceed with its Phase 2 study for Sti-3031 in advanced urothelial carcinoma. read more.....»»

Category: blogSource: benzingaApr 27th, 2021

What"s Going On With GALT Stock And TV Stock Today?

Galectin Therapeutics Inc (NASDAQ: GALT) sh.....»»

Category: blogSource: benzingaApr 14th, 2021

Why Upstart Holdings Stock Jumped 48% Today

Shares of Upstart Holdings Inc. (NASDAQ: UPST), an artificial intelligence lending platform, surged 48% in extended trading on Wednesday. read more.....»»

Category: blogSource: benzingaMar 17th, 2021

Analyzing The Price Action In Oncternal Therapeutics Stock Today

The Price And Volume Action In Oncternal Therapeutics's S.....»»

Category: blogSource: benzingaMar 17th, 2021

Why Pandion Therapeutics Stock Shot Up 133% Today

Pandion Therapeutics Inc (NASDAQ: PAND) shares closed over 133% higher today. read more.....»»

Category: blogSource: benzingaFeb 25th, 2021

Why Monopar Therapeutics And EyePoint Pharma Are Trading Higher Today

Monopar Therapeutics (NASDAQ: MNPR) shares are trading higher Thursday after Roth Capital initiated coverage on the stock with a Buy rating and a price target of $49 per share. read more.....»»

Category: blogSource: benzingaJan 28th, 2021

Why Anthem, Frequency Therapeutics And Vir Are Moving Today

Vir Biotechnology (NASDAQ: VIR) shares are trading lower Wednesday after JPMorgan downgraded the stock from Neutral to Underweight and announced a price target of $30 per share. read more.....»»

Category: blogSource: benzingaJan 27th, 2021

Why Globalstar Shares Spiked 49% Today

Globalstar Inc. (AMEX: GSAT) shares closed 48.6% higher at $1.37 on Wednesday. The satellite communications company’s stock surged as its wholly-owned subsidiary SPOT LLC announced a partnership with monthly subscription box service Battlebox. read more.....»»

Category: blogSource: benzingaJan 21st, 2021